PAR.AX

Paradigm Biopharmaceuticals Limited PAR.AX

PAR.AX
Paradigm Biopharmaceuticals Limited RCE.AX
Recce Pharmaceuticals Ltd ATH.AX
Alterity Therapeutics Limited PEB.AX
Pacific Edge Limited IMU.AX
Imugene Limited ONE.AX
Oneview Healthcare PLC ALA.AX
Arovella Therapeutics Limited EMV.AX
EMVision Medical Devices Ltd SPL.AX
Starpharma Holdings Limited EZZ.AX
EZZ Life Science Holdings Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PAR.AX RCE.AX ATH.AX PEB.AX IMU.AX ONE.AX ALA.AX EMV.AX SPL.AX EZZ.AX
6M 23.44 % 46.55 % 50.00 % 50.00 % -58.51 % -28.30 % 16.05 % -2.45 % 182.83 % 74.00 %
YTD -1.25 % -13.27 % 33.33 % 22.22 % -70.30 % -35.59 % -44.71 % -4.52 % 154.55 % -12.42 %
1Y 97.50 % -22.02 % 300.00 % 13.79 % -76.35 % -43.28 % -51.79 % -10.25 % 194.74 % -36.03 %
3Y -70.74 % -34.96 % -7.69 % -59.26 % -93.17 % 26.67 % 224.14 % 33.96 % -56.59 % 755.74 %
5Y -86.38 % -59.91 % -75.00 % -89.29 % -78.53 % 407.49 % 129.27 % -38.10 % -81.58 % 125.00 %
10Y 39.62 % 43.08 % -90.40 % -89.29 % 30.24 % -93.91 % -82.43 % 488.52 % -62.16 % 125.00 %
From the beginning 13.23 % 43.08 % -97.60 % -89.29 % -99.52 % -93.91 % -97.13 % 488.52 % -67.06 % 125.00 %

Dividend

EZZ Life Science Holdings Limited